Cite
HARVARD Citation
Babu, S. et al. (2020). Selection design phase II trial of high dosages of tamoxifen and creatine in amyotrophic lateral sclerosis. Amyotrophic lateral sclerosis and frontotemporal degeneration. 21 (1), pp. 15-23. [Online].